The Fundamentals of Cancer Genomics
If you already have an RCR login:
If you already have an RCR web account, please access the course below:
If you need to create an account:
If you don't yet have a web account (even if you're a member), please create one first:
These modules have been designed to complement existing resources, supplementing support for the new ‘mainstreaming’ delivery model of germline genetic testing whereby clinicians counsel and consent high-risk patients for genetic testing at the time of their routine oncology appointments. Access is free until August 2023 via an active RCR web account, but you are not required to be a member of the Royal College of Radiologists or the Association of Cancer Physicians.
This activity has been supported by a grant from Roche Products Limited and Astrazeneca. Roche products Limited and Astrazeneca have had no control over the educational content of this activity.
Course learning objectives
Who is this for?
Healthcare professionals involved in the care of patients with cancer, including but not limited to:
- Clinical oncologists
- Medical oncologists
- Nurses working in cancer care or cancer research
- Cancer researchers (Clinical academics or research scientists)
- Clinicians working in primary care with a specialist interest in cancer medicine
These interactive, bite-size modules are the first in what will be a series of genomics learning resources with focus on various tumour types. Look out for further details to be released in the coming months via the RCR’s channels.
The course will complement existing medical oncology, clinical oncology, and allied health professional training schemes and clinical experience, to give clinicians a deeper understanding of the molecular biology of cancer, germline predisposition to cancer, and the role of genetic variation in initiation and promotion of cancer. A unique aspect of this course is that the content will not only address heritable genetic risk factors for cancer but will also emphasise the translational application of somatic and/or genomic results in diagnostics and prognostication, as well as in directing treatment.